NASDAQ : PAHC
Phibro Animal Health Corporation — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 38.88 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.58B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.64B |
| Enterprise Value | 2.36B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | Sep 2, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 21.11M |
| Shares Outstanding | 40.60M |
| Shares Change (YoY) | +0.70% |
| Shares Change (QoQ) | -0.09% |
| Owned by Insiders (%) | 48.47% |
| Owned by Institutions (%) | 54.16% |
| Float | 20.91M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 16.67 |
| Forward PE | 11.12 |
| PS Ratio | 1.04 |
| Forward PS | 1.00 |
| PB Ratio | 4.09 |
| P/TBV Ratio | 5.34 |
| P/FCF Ratio | 160.00 |
| P/OCF Ratio | 22.89 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 22.97 |
| EV / Sales | 1.51 |
| EV / EBITDA | 9.38 |
| EV / EBIT | 11.79 |
| EV / FCF | 232.14 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.96 |
| Quick Ratio | 1.02 |
| Debt / Equity | 2.06 |
| Debt / EBITDA | 3.06 |
| Debt / FCF | 80.65 |
| Interest Coverage | 4.18 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 29.72% |
| Return on Assets (ROA) | 8.48% |
| Return on Invested Capital (ROIC) | 13.00% |
| Return on Capital Employed (ROCE) | 16.39% |
| Weighted Average Cost of Capital (WACC) | 5.79% |
| Revenue Per Employee | $582,761 |
| Profits Per Employee | $38,280 |
| Employee Count | 2,605 |
| Asset Turnover | 1.06 |
| Inventory Turnover | 2.07 |
Taxes
| Measure | Value |
|---|
| Income Tax | 37.63M |
| Effective Tax Rate | 27.40% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.42 |
| 52-Week Price Change | -5.61% |
| 50-Day Moving Average | 36.99 |
| 200-Day Moving Average | 41.26 |
| Relative Strength Index (RSI) | 56.91 |
| Average Volume (20 Days) | 196,811 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.03M |
| Short Previous Month | 1.02M |
| Short % of Shares Out | 2.54% |
| Short % of Float | 4.94% |
| Short Ratio (days to cover) | 4.10 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.52B |
| Gross Profit | 505.97M |
| Operating Income | 194.24M |
| Pretax Income | 137.35M |
| Net Income | 99.72M |
| EBITDA | 244.23M |
| EBIT | 194.24M |
| Earnings Per Share (EPS) | $2.43 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 83.98M |
| Total Debt | 795.65M |
| Net Cash | -711.67M |
| Net Cash Per Share | -$17.53 |
| Equity (Book Value) | 385.48M |
| Book Value Per Share | 9.50 |
| Working Capital | 619.04M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 68.95M |
| Capital Expenditures | -59.09M |
| Depreciation & Amortization | 49.99M |
| Net Borrowing | 13.47M |
| Free Cash Flow | 9.87M |
| FCF Per Share | $0.24 |
Margins
| Measure | Value |
|---|
| Gross Margin | 33.33% |
| Operating Margin | 12.80% |
| Pretax Margin | 9.05% |
| Profit Margin | 6.57% |
| EBITDA Margin | 16.09% |
| EBIT Margin | 12.80% |
| FCF Margin | 0.65% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $0.48 |
| Dividend Yield | 1.24% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 19.75% |
| FCF Payout Ratio | 197.53% |
| Buyback Yield | -0.70% |
| Shareholder Yield | 0.53% |
| Earnings Yield | 6.00% |
| FCF Yield | 0.62% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $47.00 |
| Price Target Difference | 16.05% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 3.41% |
| EPS Growth Forecast (3Y) | 8.47% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 3.15 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |